Methylmalonic acidemia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Quantitative analysis of mitochondrial protein expression in methylmalonic acidemia by two-dimensional difference gel electrophoresis.
|
16823967 |
2006 |
Methylmalonic aciduria
|
0.300 |
Biomarker
|
disease |
CTD_human |
Quantitative analysis of mitochondrial protein expression in methylmalonic acidemia by two-dimensional difference gel electrophoresis.
|
16823967 |
2006 |
Chloracne
|
0.300 |
Biomarker
|
disease |
CTD_human |
Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects.
|
17101203 |
2007 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Chondrocytic HCS-2/8 cells and breast cancer MDA231 cells produce over 6 times more CCN2 than any other cell type.
|
17291666 |
2007 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Chondrocytic HCS-2/8 cells and breast cancer MDA231 cells produce over 6 times more CCN2 than any other cell type.
|
17291666 |
2007 |
Thrombocytopenia 4
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia 4
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia 4
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia
|
0.650 |
Biomarker
|
phenotype |
CTD_human |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia
|
0.650 |
GeneticVariation
|
phenotype |
LHGDN |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia
|
0.650 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia
|
0.650 |
GeneticVariation
|
phenotype |
LHGDN |
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin.
|
19172527 |
2009 |
Hyperferritinemia, hereditary, with congenital cataracts
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Taken together, spontaneous mutation in the IRE of L-ferritin may cause non-H-HCS by the same mechanism as HHCS.
|
19800271 |
2010 |
Refractory anemias
|
0.010 |
Biomarker
|
disease |
BEFREE |
CYC and etanercept (ETN) were administered to 62 and 24 RA patients, respectively, who were confirmed with biopsy as having AA amyloidosis.
|
22879465 |
2012 |
Rheumatoid Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CYC and etanercept (ETN) were administered to 62 and 24 RA patients, respectively, who were confirmed with biopsy as having AA amyloidosis.
|
22879465 |
2012 |
Reactive systemic amyloidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CYC and etanercept (ETN) were administered to 62 and 24 RA patients, respectively, who were confirmed with biopsy as having AA amyloidosis.
|
22879465 |
2012 |
AA amyloidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CYC and etanercept (ETN) were administered to 62 and 24 RA patients, respectively, who were confirmed with biopsy as having AA amyloidosis.
|
22879465 |
2012 |
Thrombocytopenia
|
0.650 |
GeneticVariation
|
phenotype |
BEFREE |
In the last 5 years, nine new genes whose mutations are responsible for thrombocytopenia have been identified, and this also led to the recognition of several novel nosographic entities, such as thrombocytopenias deriving from mutations in CYCS, TUBB1, FLNA, ITGA2B/ITGB3, ANKRD26 and ACTN1.
|
23636669 |
2013 |
Chondrosarcoma
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS-2/8) cells that were infected with lentivirus expressing constitutively active mutants of FGFR3-K650E causing thanatophoric dysplasia, FGFR3-K650M causing SADDAN, and FGFR3-G380R causing ACH.
|
24324705 |
2013 |
Cystinuria
|
0.010 |
Biomarker
|
disease |
BEFREE |
The affected siblings display a recognizable phenotype which is similar to atypical HCS with regard to growth failure and neuro-muscular features, but is characterized by lack of cystinuria.
|
23794250 |
2013 |
Failure to Thrive
|
0.010 |
Biomarker
|
disease |
BEFREE |
The affected siblings display a recognizable phenotype which is similar to atypical HCS with regard to growth failure and neuro-muscular features, but is characterized by lack of cystinuria.
|
23794250 |
2013 |
Floppy infant syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome (HCS, OMIM606407) is characterized by infantile hypotonia, poor feeding, and growth hormone deficiency.
|
23794250 |
2013 |
Somatotropin deficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome (HCS, OMIM606407) is characterized by infantile hypotonia, poor feeding, and growth hormone deficiency.
|
23794250 |
2013 |
Growth failure
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The affected siblings display a recognizable phenotype which is similar to atypical HCS with regard to growth failure and neuro-muscular features, but is characterized by lack of cystinuria.
|
23794250 |
2013 |
Hypotonia-Cystinuria Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome (HCS, OMIM606407) is characterized by infantile hypotonia, poor feeding, and growth hormone deficiency.
|
23794250 |
2013 |